Trial intelligence / Profile preview

Effect of aripiprazole on prevention of delirium

IRCT2017011810178N12Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Jan 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of aripiprazole in delirium, sponsored by Shahid Beheshti University of Medical Sciences. Started Jan 2017; status: completed.

02

Drugs

aripiprazole
03

Conditions

delirium

Beyond the preview

Go deeper on IRCT2017011810178N12.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2017011810178N12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call